Contrast-enhanced imaging is indicated as the diagnostic benefit outweighs the risk, even in the setting of elevated creatinine. Current evidence (ACR/NKF) suggests the risk of contrast-associated AKI is lower than previously believed, and necessary imaging should not be delayed when it will impact management. Renal-protective measures, including volume optimization and avoidance of nephrotoxins, will be considered.